Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Healthcare Triangle (HCTI) Operating Income (2020 - 2025)

Historic Operating Income for Healthcare Triangle (HCTI) over the last 6 years, with Q3 2025 value amounting to -$2.6 million.

  • Healthcare Triangle's Operating Income fell 12202.23% to -$2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.8 million, marking a year-over-year decrease of 392.89%. This contributed to the annual value of -$4.8 million for FY2024, which is 3825.86% up from last year.
  • According to the latest figures from Q3 2025, Healthcare Triangle's Operating Income is -$2.6 million, which was down 12202.23% from -$1.4 million recorded in Q2 2025.
  • Over the past 5 years, Healthcare Triangle's Operating Income peaked at $469000.0 during Q2 2021, and registered a low of -$10.7 million during Q4 2022.
  • For the 5-year period, Healthcare Triangle's Operating Income averaged around -$2.1 million, with its median value being -$1.5 million (2023).
  • Per our database at Business Quant, Healthcare Triangle's Operating Income crashed by 102519.99% in 2021 and then skyrocketed by 8718.72% in 2023.
  • Healthcare Triangle's Operating Income (Quarter) stood at -$3.3 million in 2021, then crashed by 219.53% to -$10.7 million in 2022, then soared by 87.19% to -$1.4 million in 2023, then skyrocketed by 63.57% to -$498000.0 in 2024, then crashed by 420.28% to -$2.6 million in 2025.
  • Its Operating Income stands at -$2.6 million for Q3 2025, versus -$1.4 million for Q2 2025 and -$1.4 million for Q1 2025.